JUL 22, 2019 2:39 PM PDT

New Freezing Technique for Breast Cancer Patients in Low Income Countries

WRITTEN BY: Julia Travers

Treatment for breast cancer can be too expensive and hard to access for many women in lower-income countries. These women are disproportionately affected by breast cancer and experience a higher related mortality rate. In the United States, more than 90 percent of women survive breast cancer. But in countries like The Gambia, Saudi Arabia or Uganda, survival rates are much lower, ranging from about 12 to 64 percent.

A student-led research team of the Biomedical Engineering Design Program at Johns Hopkins University is creating a novel approach to bringing successful treatment to more breast cancer patients around the world. Many of these women cannot afford or reach procedures like chemotherapy, radiation and surgery. Cryoablation, or killing cancerous tissue by freezing it, can be preferable because it does not require an operating room or anesthesia and so can be performed in community clinics.

This technique typically uses argon gas, which can cost as much as $10,000 per treatment and can be hard to come by in many parts of the world. The Johns Hopkins team used carbon dioxide instead, which is much cheaper and easier to find. According to EurekAlert, they tested this procedure in three experiments that mimicked the temperatures and conditions of human breasts, finding it could successfully kill tumor tissue. The three test materials or environments were ultrasound gel, rats with mammary tumors and the normal liver of a pig. The device met standard freezing temperatures for tissue death for similar U.S. devices and killed at least 85 percent of the tumor tissue.

"Innovation in cancer care doesn't always mean you have to create an entirely new treatment, sometimes it means radically innovating on proven therapies such that they're redesigned to be accessible to the majority of the world's population," Bailey Surtees, the study's first author and a Johns Hopkins University biomedical engineering graduate, said. The researchers now plan to continue testing the device for use with people and also hope to broaden its application to pets. Their findings were published in July 2019 in PLOS One.

 

An animation of the procedure is below:

 

 

Source: EurekAlert

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech and conservation.
You May Also Like
JAN 27, 2020
Genetics & Genomics
JAN 27, 2020
A Way to Predict Which Microbes Can Cause Cancer
Researchers have created a technique that can identify bacteria and viruses that are linked to cancer....
JAN 27, 2020
Cancer
JAN 27, 2020
Using deep learning to find the patterns of cancer
Research published recently in the journal Life Science Alliance uses deep learning to analyze genomic data from colorectal tumors to ameliorate diagnosis ...
JAN 27, 2020
Clinical & Molecular DX
JAN 27, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
JAN 27, 2020
Immunology
JAN 27, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
JAN 27, 2020
Cancer
JAN 27, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells...
JAN 27, 2020
Drug Discovery & Development
JAN 27, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
Loading Comments...